CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Novo Holdings A/S is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Novo Holdings A/S
Tuborg Havnevej 19
Phone: +45 3527 6500p:+45 3527 6500 Hellerup, 2900  Denmark
This is a Subsidiary, click here for the Parent Company
Business Summary
Novo Holdings A/S is a holding and investment company, wholly owned by the Novo Nordisk Foundation. The Company's investments include Life Science Investments and Financial Investments. At the end of 2018, its Principal Investments portfolio comprised 13 companies of which eleven are located in Europe and two in the US. The portfolio consists of majority positions in Sonion and Xellia, both headquartered in Denmark, and minority positions in Chr. Hansen, Symphogen, SYNLAB, Orexo, Veloxis, BTG, ConvaTec, Evotec, Envirotainer (all European) and ERT and Inogen (both American).
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202112/31/2021Yes----

Industries
SIC Code Description
6141 Personal credit institutions
6799 Investors, not elsewhere classified
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer KasimKutay
Chief Financial Officer PeterHaahr
Chairman, Board of Directors Lars RebienSørensen

Business Names
Business Name
Altasciences Company, Inc.
BBI Group
BiOrigin ApS
17 additional Business Names available in full report.

General Information
Number of Employees: 68 (As of 12/31/2018)


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, October 3, 2022